Rabia Bajwa, MD
Sleep Medicine · Indiana, PANPI 1699730465
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,838 of the $2,277 with a category attached, or 80.7%. It is spread thinly across 18 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 117 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$522
- Axsome Therapeutics, Inc.$404
- Harmony Biosciences LLC$301
- GSK$263
- Resmed Corp$177
- Boehringer Ingelheim$114
- plus $496 from 12 others
What the payments were for
- Consulting fees$1507%
- Food & beverage$1,83881%
- Education$28913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 17 | $522 |
| Axsome Therapeutics, Inc. | 24 | $404 |
| Harmony Biosciences LLC | 8 | $301 |
| GSK | 27 | $263 |
| Resmed Corp | 5 | $177 |
| Boehringer Ingelheim | 8 | $114 |
| AstraZeneca | 4 | $88 |
| Sanofi | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 5 | $76 |
| Philips North America LLC | 4 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Novartis | 2 | $28 |
| Merck | 2 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Circassia Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,277 in reported general payments places this provider in the 65th percentile of 87 sleep medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 45 | $3,683 |
| Modafinil | 59 | $2,534 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 48 | $608 |
| Ropinirole Hcl | 26 | $136 |
| Gabapentin | 22 | $86 |
| Trazodone Hcl | 15 | $30 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Indiana
- Chandra Matadeen-AliGlen Mills$2.3M
- Pratima BehariCamp Hill$108K
- Olufunke Afolabi-BrownHorsham$93K
- Karl DoghramjiPhiladelphia$85K
- Richard SchwabPhiladelphia$81K
- Ralph GalloWynnewood$80K
- Gaurav PatelMedia$45K
- Maria SunseriPittsburgh$23K
- Michael WeinsteinLansdale$18K
- Nalaka GooneratnePhiladelphia$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.